0001179110-15-001899.txt : 20150204 0001179110-15-001899.hdr.sgml : 20150204 20150204205216 ACCESSION NUMBER: 0001179110-15-001899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150202 FILED AS OF DATE: 20150204 DATE AS OF CHANGE: 20150204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Washington Robin L CENTRAL INDEX KEY: 0001327145 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 15577212 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0306 4 2015-02-02 0 0000882095 GILEAD SCIENCES INC GILD 0001327145 Washington Robin L GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, CFO Common Stock 2015-02-02 4 M 0 11550 19.085 A 61382 D Common Stock 2015-02-02 4 M 0 4800 23.755 A 66182 D Common Stock 2015-02-02 4 M 0 11250 24.295 A 77432 D Common Stock 2015-02-02 4 M 0 5592 40.56 A 83024 D Common Stock 2015-02-02 4 S 0 24392 105.1379 D 58632 D Common Stock 2015-02-02 4 S 0 8200 105.9789 D 50432 D Common Stock 2015-02-02 4 S 0 600 106.8517 D 49832 D Non-Qualified Stock Option (right to buy) 19.085 2015-02-02 4 M 0 11550 0 D 2021-01-20 Common Stock 11550 0 D Non-Qualified Stock Option (right to buy) 23.755 2015-02-02 4 M 0 4800 0 D 2020-01-28 Common Stock 4800 0 D Non-Qualified Stock Option (right to buy) 24.295 2015-02-02 4 M 0 11250 0 D 2022-01-26 Common Stock 11250 45000 D Non-Qualified Stock Option (right to buy) 40.56 2015-02-02 4 M 0 5592 0 D 2023-02-01 Commmon Stock 5592 44750 D The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Sale prices reported for the transactions reported here range from $104.63 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $105.64 to $106.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $106.71 to $107.07. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ John F. Milligan by Power of Attorney for Robin L. Washington 2015-02-04